Your browser doesn't support javascript.
loading
ASXL1/TET2 genotype-based risk stratification outperforms ASXL1 mutational impact and is independent of mutant variant allele fractions in chronic myelomonocytic leukemia.
Csizmar, Clifford M; Gurney, Mark; Kanagal-Shamanna, Rashmi; Chien, Kelly; Hammond, Danielle; Lasho, Terra L; Finke, Christy M; Dean, Christopher; Natu, Anuya; Mangaonkar, Abhishek A; Al-Kali, Aref; Gangat, Naseema; Tefferi, Ayalew; Alkhateeb, Hassan; Garcia-Manero, Guillermo; Komrokji, Rami S; Ali, Najla A; Padron, Eric; Montalban-Bravo, Guillermo; Patnaik, Mrinal M.
Afiliação
  • Csizmar CM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Gurney M; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Chien K; Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Hammond D; Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Lasho TL; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Finke CM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Dean C; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Natu A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Mangaonkar AA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Al-Kali A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Gangat N; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Tefferi A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Alkhateeb H; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Garcia-Manero G; Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Komrokji RS; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Ali NA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Padron E; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Montalban-Bravo G; Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Patnaik MM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN. patnaik.mrinal@mayo.edu.
Haematologica ; 2024 Jun 20.
Article em En | MEDLINE | ID: mdl-38899337
ABSTRACT
Not available.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Haematologica Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Haematologica Ano de publicação: 2024 Tipo de documento: Article